4.6 Article

Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide

A. Faurschou et al.

ACTA DIABETOLOGICA (2014)

Review Dermatology

Innate immunity in the pathogenesis of psoriasis

Cheryl M. Sweeney et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)

Article Medicine, Research & Experimental

Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

Annesofie Faurschou et al.

MEDICAL HYPOTHESES (2011)

Article Medicine, General & Internal

Obesity, waist circumference, weight change, and the risk of psoriasis in women - Nurses' health study II

Arathi R. Setty et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Article Endocrinology & Metabolism

Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery

LA Vazquez et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)